Shanghai Shen Lian Biomedical Corporation
Shanghai Shen Lian Biomedical Corporation, often referred to as Shen Lian Bio, is a prominent player in the biotechnology industry, headquartered in Shanghai, China. Founded in 2005, the company has established itself as a leader in the development and production of innovative biopharmaceuticals and diagnostic products, primarily serving the Asian market. Shen Lian Bio focuses on core areas such as monoclonal antibodies, recombinant proteins, and in vitro diagnostic reagents. Their unique approach combines cutting-edge technology with rigorous quality control, ensuring high efficacy and safety in their offerings. The company has achieved significant milestones, including various certifications and partnerships that enhance its market position. With a commitment to advancing healthcare solutions, Shanghai Shen Lian Biomedical Corporation continues to make strides in the biopharmaceutical sector, contributing to improved patient outcomes and solidifying its reputation as a trusted name in biotechnology.
DitchCarbon Score
How does Shanghai Shen Lian Biomedical Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shanghai Shen Lian Biomedical Corporation's score of 15 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shanghai Shen Lian Biomedical Corporation's reported carbon emissions
Shanghai Shen Lian Biomedical Corporation currently does not have available carbon emissions data, as no specific figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting on its emissions. In the context of the biomedical industry, it is increasingly important for companies to establish clear sustainability goals and transparent reporting practices to align with global climate action efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shanghai Shen Lian Biomedical Corporation is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
